Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Oscar Health ( (OSCR) ) has shared an announcement.
On September 11, 2025, Oscar Health, Inc. amended its investment agreement to facilitate a private offering of $350 million in convertible senior subordinated notes due 2030. The proceeds from this offering are intended to support Oscar’s long-term growth initiatives, including strategic AI projects and enhancing consumer healthcare experiences, as well as potentially terminating its revolving credit facility.
The most recent analyst rating on (OSCR) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Oscar Health stock, see the OSCR Stock Forecast page.
Spark’s Take on OSCR Stock
According to Spark, TipRanks’ AI Analyst, OSCR is a Outperform.
Oscar Health’s strong financial performance and positive technical indicators are the primary drivers of its stock score. However, the negative P/E ratio and operational challenges highlighted in the earnings call weigh down the overall score. The company’s strategic initiatives and future profitability goals provide a cautiously optimistic outlook.
To see Spark’s full report on OSCR stock, click here.
More about Oscar Health
Oscar Health, Inc. is a leading healthcare technology company focused on serving its members through a comprehensive technology platform.
Average Trading Volume: 27,349,027
Technical Sentiment Signal: Strong Buy
Current Market Cap: $5B
For detailed information about OSCR stock, go to TipRanks’ Stock Analysis page.